| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $10,116,390 ) (Continued on the next page) |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K02AG076883 | Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | 000 | 2 | NIH | 11/2/2023 | $151,740 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI174615 | Characterization of the SARS-CoV-2-mediated piracy of p38? | 000 | 1 | NIH | 11/22/2023 | $47,694 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30MH129055 | Long-range and local connectivity of cholinergic interneurons in the nucleus accumbens | 000 | 3 | NIH | 11/20/2023 | $52,694 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21ES034811 | ALKBH5 and nickel-induced lung carcinogenesis | 000 | 2 | NIH | 11/27/2023 | $211,875 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI180737 | Thromboinflammatory pathways triggered by gut dysbiosis in patients with Lupus | 000 | 1 | NIH | 11/27/2023 | $228,825 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 000 | 2 | NIH | 11/13/2023 | $625,153 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NR018916 | Personalized Dietary Management in Type 2 Diabetes | 000 | 4 | NIH | 11/16/2023 | $607,080 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL157220 | Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor | 000 | 3 | NIH | 11/6/2023 | $614,424 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA248175 | Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma | 000 | 4 | NIH | 11/15/2023 | $414,767 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | H7600043 | Ryan White Part C Outpatient EIS Program | 00 | 33 | HRSA | 11/16/2023 | $151,255 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1AI148574 | Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | 000 | 5 | NIH | 11/15/2023 | $556,480 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL045095 | Pathways of Tissue Lipid Uptake | 000 | 32 | NIH | 11/17/2023 | $692,136 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI176335 | Interplay between nuclear stress responses and herpesvirus latency | 000 | 1 | NIH | 11/8/2023 | $605,732 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI174932 | Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV Epidemiology | 000 | 2 | NIH | 10/31/2023 | $684,384 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES031658 | Defining the molecular basis of oncogene-induced replication stress | 000 | 4 | NIH | 10/26/2023 | $426,547 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES031402 | Persistent transcriptional changes induced by nickel through epigenetic alterations | 000 | 5 | NIH | 10/23/2023 | $401,167 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI108680 | Decreasing antibiotic prescribing in acute respiratory infections through implementation of nurse driven clinical decision support | 000 | 11 | NIH | 11/9/2023 | $640,200 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK135088 | Dynamics and mechanism of sodium-dependent carboxylate transporters | 000 | 2 | NIH | 11/22/2023 | $580,275 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK132395 | Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | 000 | 2 | NIH | 11/27/2023 | $620,778 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG075272 | Dissecting CEBPB Function with Synthetic Biology and Imaging | 000 | 3 | NIH | 11/20/2023 | $580,863 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00ES030403 | Nonpersistent chemical exposure, placental development, and maternal pre- and post-pregnancy cardiovascular health | 000 | 5 | NIH | 11/28/2023 | $248,784 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK127916 | BRinging the Diabetes Prevention Program to GEriatric Populations (BRIDGE) | 000 | 3 | NIH | 11/28/2023 | $634,416 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23DK124570 | The Role of Enteric Infection in Flares of Inflammatory Bowel Disease | 000 | 4 | NIH | 11/21/2023 | $199,260 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA269898 | Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment | 000 | 2 | NIH | 11/15/2023 | $520,382 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC012557 | Synaptic basis of perceptual learning with cochlear implants in rat auditory cortex - Renewal | 002 | 12 | NIH | 11/14/2023 | $604,873 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33EY033689 | VIS4ION-Thailand (Visually Impaired Smart Service System for Spatial Intelligence and Onboard Navigation) - Resub - 1 | 000 | 3 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30AI154907 | Structural characterization of MCE mediated lipid transport across the Mycobacterial cell envelope | 000 | 4 | NIH | 10/20/2023 | -$29,345 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG1DA013035 | NIDA Clinical Trials Network: New York Node | 000 | 22 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR082225 | Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury | 000 | 1 | NIH | 11/20/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG1DA013035 | NIDA Clinical Trials Network: New York Node | 000 | 22 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR076900 | Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes | 000 | 4 | NIH | 11/3/2023 | -$404,820 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UH3CA261067 | Optimizing the use of ketamine to reduce chronic postsurgical pain | 000 | 4 | NIH | 11/1/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG1DA013035 | NIDA Clinical Trials Network: New York Node | 000 | 22 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR062207 | The immunological mechanism of PGRNs anti-inflammatory effect | 000 | 10 | NIH | 11/3/2023 | -$536,957 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG1DA013035 | NIDA Clinical Trials Network: New York Node | 000 | 22 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01FD007826 | Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients with Familial Dysautonomia | 000 | 1 | FDA | 10/22/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081034 | Micro-TeACH (Microbiome Technology and Analytic Center Hub) | 000 | 2 | NIH | 11/15/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01FD007826 | Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients with Familial Dysautonomia | 000 | 1 | FDA | 10/22/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI136901 | C-terminal proteolysis in the Pseudomonas aeruginosa cell envelope | 000 | 5 | NIH | 11/3/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081034 | Micro-TeACH (Microbiome Technology and Analytic Center Hub) | 000 | 2 | NIH | 11/15/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG079175 | Leveraging Electronic Health Records for Reducing Dementia Screening Disparities in Diverse Communities | 000 | 1 | NIH | 11/21/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DA055338 | 8/24 The Healthy Brain and Child Development National Consortium | 000 | 3 | NIH | 11/16/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00AG071735 | Quantitative assessment of early structural and functional changes in aging skeletal muscle | 000 | 3 | NIH | 10/27/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P01NS074972 | Development and Function of 5HT3aR-Expressing Cortical GABAergic Interneurons | 000 | 10 | NIH | 11/15/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DA055338 | 8/24 The Healthy Brain and Child Development National Consortium | 000 | 3 | NIH | 11/16/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01CA260432 | Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 1 | 000 | 2 | NIH | 11/13/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T32GM136573 | Medical Scientist Research Service Award | 000 | 4 | NIH | 10/13/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC021826 | Odorprint Based Disease Diagnostics | 000 | 1 | NIH | 10/12/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | RM1DA059377 | Person-centered quality measurement and management in a system for addictions treatment in New York State | 000 | 1 | NIH | 11/2/2023 | $0 |
|
